Jounce Therapeutics, Inc. (JNCE) stock price traded with surging change along with the volume 0.29 million shares in Friday trading session. Shares are trading price at $4.40 with move of 5.01%. The company’s 3-months average volume stands at 0.32 million. When we divide the last trade volume by the 3-month average volume, we found out a relative volume of 0.88. Recent trade price levels places JNCE’s stock about -84.96% away from the 52-week high and closed 65.41% away from the 52-week low. The total dollar value of all 35.22 million outstanding shares is 0.15 billion.
Jounce Therapeutics, Inc. (JNCE)’s current distance from 20-Day Simple Moving Average is 4.14% and standing 10.41% away from 50-Day Simple Moving Average while traded down -43.23% from 200-Day Simple Moving Average. The stock has advanced 65.41% to a low over the previous 12 months and showed declining move -84.96% to a high over the same period. Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance. They may also be used to assist the trader figure out proper support and resistance levels for the stock.
Let’s take an assessment at how Jounce Therapeutics, Inc. (JNCE) has been performing. The stock go up so far this year; showing a rise of 30.56% and added with positive flow of 21.55% during recent week. The shares price has positioned 4.27% up over the past quarter while it has directed -35.95% toward a falling position throughout past six months. The shares price has directed -81.80% toward a lower level throughout last year and swapped 13.70% toward a strong spot during past one month.
77.50% shares of the company possessed by Institutional Investors. The net percent change held by Institutional Investors has seen a change of -4.12% in last three month period. Insiders own 0.40% of Jounce Therapeutics, Inc. (JNCE) shares. During last six month record, the net percent change kept by insiders has observed a change of 0.00%. The stock volatility for week was 9.16% while for month was 9.35%.
Return on Assets (ROA) ratio indicates how profitable a company is relative to its total assets. The ROA is -13.10%. A company that manages their assets well will have a high return, while if manages their assets poorly will have a low return.
Common shareholders want to know how profitable their capital is in the businesses they invest it in. The company gives a ROE of -28.40%. The higher the ROE, the better the company is at generating profits.
ROI is -11.50%. A positive result means that returns exceed costs. Analysts therefore consider the investment a net gain. The opposite kind of result, a negative means that costs outweigh returns. Analysts therefore view the investment as a net loss.
ATR value of company was 0.36. Average True Range (ATR) is an indicator based on trading ranges smoothed by an N-period exponential moving average percentage of the true range values. ATR can display volatility of stocks, ETFs and indexes. The principal of ATR is very similar to other volatility indicators: A high ATR value signals a possible trend change. A low ATR value correlates with a weaker trend movement.
Currently Analysts have a mean recommendation of 2.50 on the shares. This is based on a 1-5 numeric scale where Rating Scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell, 5.0 Strong Sell.
Albert has over 14 years experience in the financial services industry giving him a vast understanding of how news affects the financial markets. He is an active day trader spending the majority of his time analyzing earnings reports and watching commodities and derivatives. He has a Masters Degree in Economics from Westminster University with previous roles counting Investment Banking.